Article Text

Download PDFPDF
Pharmacological interventions
Is long-acting injectable aripiprazole useful for the treatment of acute exacerbation of schizophrenia?

Statistics from


  • Competing interests YT has received grant funding from Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science and speaker's honoraria from Dainippon-Sumitomo Pharma, Otsuka, Meiji-Seika Pharma and Janssen Pharmaceutical, within the past 3 years. AS is or has been consultant/speaker for Abbott, AbbVie, Angelini, Astra Zeneca, Clinical Data, Boehringer, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Innovapharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polipharma, Sanofi and Servier.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.